Skip to content
value.today

WellDoc, Inc.

Total raised
$60 M
6 rounds on record
Latest round
$29 M
Dec 2015
First round on record
Feb 2006
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of WellDoc, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2015$29 MNo. 6$10 to $50 million

WellDoc, Inc.: Raise no. 6, Dec 2015

Investors in this round

58 investors had bought by the notice of Apr 4, 2016: 58 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $32 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,250,000
Finders' fees
none
Paid to its own people
$1,125,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brandon I. Gretz · Executive Officer
  • Caroline I. York · Executive Officer
  • Jen I. Beachell · Executive Officer
  • Kevin McRaith · Executive Officer, Director
  • David I. Stevenson · Director
  • David Levy · Director
  • Donald V. Almeida · Director
  • Hyuk-Jeen Suh · Director
  • Juan Enriquez · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Cowen and Company (CRD 7616) · New York, New YorkSold in CA, CO, CT, DE, FL, IL, MA, MD, MN, MO, NJ, NY, PA, TN, VA, WA, WI

Remarks in the notice

  • On fees: “Amount consisted of a $900,000 cash payment and issuance of shares of Series B Stock in the amount of $350,000.”
  • On the amounts: “Includes cash proceeds of $15,949,997.20, conversion of debt and issuance of equity pursuant to certain Agreements for Future Equity.”

Signed by Kevin McRaith, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 4, 2016. Read the notice at the SEC.

equitySEC
Nov 2014$5 MNo. 5$2 to $10 million

WellDoc, Inc.: Raise no. 5, Nov 2014

Investors in this round

30 investors had bought by the notice of Mar 10, 2015: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kevin I. McRaith · Executive Officer
  • Ryan Sysko · Executive Officer, Director
  • Suzanne I. Clough · Executive Officer
  • David Levy · Director
  • Donald V. Almeida · Director
  • Maxwell I. Kahn · Director
  • Michael I. Greenebaum · Director
  • Terry Lierman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin McRaith, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Mar 10, 2015. Read the notice at the SEC.

equity, optionsSEC
Nov 2013$16 MNo. 4$10 to $50 million

WellDoc, Inc.: Raise no. 4, Nov 2013

Investors in this round

13 investors had bought by the notice of Jan 9, 2014: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $20 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anand K. Iyer · Executive Officer
  • Chris I. Bergstrom · Executive Officer
  • Ryan Sysko · Executive Officer, Director
  • Suzanne I. Clough · Executive Officer
  • David K. Levy · Director
  • Donald V. Almeida · Director
  • Maxwell I. Kahn · Director
  • Michael I. Greenebaum · Director
  • Terry K. Lierman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ryan Sysko, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 9, 2014. Read the notice at the SEC.

equity, optionsSEC
Jul 2012$8 MNo. 3$2 to $10 million

WellDoc, Inc.: Raise no. 3, Jul 2012

Investors in this round

9 investors had bought by the notice of Oct 21, 2013: 8 accredited, 1 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $10 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$208,042
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Maryland

People named in the notice

  • Anand Iyer · Executive Officer, Director
  • Chris Bergstrom · Executive Officer
  • Ryan Sysko · Executive Officer, Director
  • Suzanne Clough · Executive Officer
  • David Levy · Director
  • Don Almeida · Director
  • Michael Greenebaum · Director
  • Terry Lierman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Healthios Capital Markets LLC (CRD 115542) · Northbrook, IllinoisSold in CA, CT, FL, IL, MA, MO, NC, NJ, NY, PA

Signed by Ryan Sysko, Ceo. Source: SEC Form D, newest notice filed Oct 21, 2013. Read the notice at the SEC.

equitySEC
Dec 2007$1 MNo. 2Under $2 million

WellDoc, Inc.: Raise no. 2, Dec 2007

Investors in this round

1 investor had bought by the notice of Dec 20, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Maryland

People named in the notice

  • Anand K. Iyer · Executive Officer, Director
  • Chris I. Bergstrom · Executive Officer
  • Ryan Sysko · Executive Officer, Director
  • Suzanne I. Clough · Executive Officer
  • David K. Levy · Director
  • Donald V. Almeida · Director
  • Michael I. Greenebaum · Director
  • Terry K. Lierman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ryan Sysko, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 20, 2013. Read the notice at the SEC.

equitySEC
Feb 2006$1 MNo. 1Under $2 million

WellDoc, Inc.: Raise no. 1, Feb 2006

Investors in this round

1 investor had bought by the notice of Dec 20, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Maryland

People named in the notice

  • Anand K. Iyer · Executive Officer, Director
  • Chris I. Bergstrom · Executive Officer
  • Ryan Sysko · Executive Officer, Director
  • Suzanne I. Clough · Executive Officer
  • David K. Levy · Director
  • Donald V. Almeida · Director
  • Michael I. Greenbaum · Director
  • Terry K. Lierman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ryan Sysko, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 20, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • WellDoc, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2016).

    SEC Form D · Apr 2016

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2016

That is all the official record says: WellDoc, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of WellDoc, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 58 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by WellDoc, Inc.
NameRoleNamed in
Brandon I. GretzExecutive officerApr 2016
Caroline I. YorkExecutive officerApr 2016
Jen I. BeachellExecutive officerApr 2016
Kevin McRaithExecutive officerApr 2016
Anand K. Iyer, Ph.DExecutive officerDec 2015
Caroline K. YorkExecutive officerDec 2015
Jen K. BeachellExecutive officerDec 2015
Suzanne I. Clough, MDExecutive officerDec 2015
Kevin I. McRaithExecutive officerMar 2015
Ryan SyskoExecutive officerMar 2015
Suzanne I. CloughExecutive officerMar 2015
Anand K. IyerExecutive officerJan 2014
Chris I. BergstromExecutive officerJan 2014
Anand IyerExecutive officerOct 2013
Chris BergstromExecutive officerOct 2013
Suzanne CloughExecutive officerOct 2013
David I. StevensonDirectorApr 2016
David LevyDirectorApr 2016
Donald V. AlmeidaDirectorApr 2016
Hyuk-Jeen SuhDirectorApr 2016
Juan EnriquezDirectorApr 2016
Kevin McRaithDirectorApr 2016
Michael GreenebaumDirectorDec 2015
Terry LiermanDirectorDec 2015
Maxwell I. KahnDirectorMar 2015
Michael I. GreenebaumDirectorMar 2015
Ryan SyskoDirectorMar 2015
David K. LevyDirectorJan 2014
Terry K. LiermanDirectorJan 2014
Anand K. IyerDirectorDec 2013
Michael I. GreenbaumDirectorDec 2013
Anand IyerDirectorOct 2013
Don AlmeidaDirectorOct 2013